{"id":"pfizer-depo-medrol","safety":{"commonSideEffects":[{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Hypertension"},{"rate":null,"effect":"Insomnia and mood changes"},{"rate":null,"effect":"Immunosuppression and increased infection risk"},{"rate":null,"effect":"Osteoporosis with long-term use"},{"rate":null,"effect":"Gastrointestinal upset"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Methylprednisolone binds to glucocorticoid receptors in the cytoplasm, translocates to the nucleus, and modulates gene transcription to decrease production of inflammatory mediators (IL-1, IL-6, TNF-α) and reduce immune cell proliferation and migration. This broad anti-inflammatory and immunosuppressive action makes it effective across multiple inflammatory and autoimmune conditions.","oneSentence":"Methylprednisolone is a corticosteroid that suppresses the immune system and reduces inflammation by inhibiting pro-inflammatory cytokine production and immune cell activation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:50:24.019Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Inflammatory and autoimmune disorders (rheumatoid arthritis, lupus, vasculitis)"},{"name":"Allergic reactions and asthma exacerbations"},{"name":"Cerebral edema and spinal cord injury"},{"name":"Hematologic malignancies (adjunctive therapy)"}]},"trialDetails":[{"nctId":"NCT04233164","phase":"EARLY_PHASE1","title":"Genomic Effects of Glucocorticoids in Patients With Systemic Lupus Erythematosus","status":"COMPLETED","sponsor":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)","startDate":"2020-03-04","conditions":"Systemic Lupus Erythematous (SLE)","enrollment":47},{"nctId":"NCT06532318","phase":"PHASE3","title":"Comparative Study Between Platelet Rich Plasma and Steroid Injection in Trigger Finger Treatment","status":"NOT_YET_RECRUITING","sponsor":"Obafemi Awolowo University Teaching Hospital","startDate":"2024-07-24","conditions":"Trigger Finger Disorder","enrollment":40},{"nctId":"NCT05941130","phase":"PHASE4","title":"3D Evaluation of Postoperative Edema After Third Molar Surgery","status":"UNKNOWN","sponsor":"Implantology Institute","startDate":"2022-07-01","conditions":"Molar, Third, Third Molar Surgery, Soft Tissue Swelling","enrollment":40},{"nctId":"NCT02798523","phase":"PHASE1","title":"Genomic Responses of Human Immune and Non-Immune Cells to Glucocorticoids","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2017-01-24","conditions":"Normal Physiology","enrollment":33},{"nctId":"NCT03640949","phase":"PHASE2, PHASE3","title":"Vasopressin and Methylprednisolone for In-Hospital Cardiac Arrest","status":"COMPLETED","sponsor":"Lars Wiuff Andersen","startDate":"2018-09-17","conditions":"Heart Arrest","enrollment":501},{"nctId":"NCT04980105","phase":"PHASE3","title":"Intra-articular Injections of Platelet-rich Plasma, Hyaluronic Acid, or Corticosteroids for Knee Osteoarthritis","status":"UNKNOWN","sponsor":"University of Wasit","startDate":"2020-03-02","conditions":"Osteoarthritis, Knee","enrollment":150},{"nctId":"NCT04617561","phase":"PHASE4","title":"Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II","status":"UNKNOWN","sponsor":"West China Hospital","startDate":"2020-11-01","conditions":"Hepatitis, Autoimmune, Primary Biliary Cholangitis","enrollment":90},{"nctId":"NCT04318652","phase":"PHASE4","title":"OCT Guided Punctal Stenosis Management","status":"COMPLETED","sponsor":"Tanta University","startDate":"2018-09-02","conditions":"Epiphora Due to Insufficient Drainage","enrollment":80},{"nctId":"NCT01977781","phase":"PHASE1","title":"Safety and Efficacy of Topical Tacrolimus 0.05% in the Treatment of Ocular Graft-Versus-Host Disease","status":"COMPLETED","sponsor":"Massachusetts Eye and Ear Infirmary","startDate":"2013-12","conditions":"Ocular GVHD","enrollment":40},{"nctId":"NCT00989729","phase":"NA","title":"Preoperative Methylprednisolone in Endovascular Aortic Repair","status":"COMPLETED","sponsor":"Louise de la Motte","startDate":"2009-10","conditions":"Abdominal Aortic Aneurysms","enrollment":150}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":4,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Pfizer Depo-medrol","genericName":"Pfizer Depo-medrol","companyName":"Obafemi Awolowo University Teaching Hospital","companyId":"obafemi-awolowo-university-teaching-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Methylprednisolone is a corticosteroid that suppresses the immune system and reduces inflammation by inhibiting pro-inflammatory cytokine production and immune cell activation. Used for Inflammatory and autoimmune disorders (rheumatoid arthritis, lupus, vasculitis), Allergic reactions and asthma exacerbations, Cerebral edema and spinal cord injury.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}